Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 12;15(6):e0234095.
doi: 10.1371/journal.pone.0234095. eCollection 2020.

Validity, reliability and cut-offs of the Patient Health Questionnaire-9 as a screening tool for depression among patients living with epilepsy in Rwanda

Affiliations

Validity, reliability and cut-offs of the Patient Health Questionnaire-9 as a screening tool for depression among patients living with epilepsy in Rwanda

Fidèle Sebera et al. PLoS One. .

Abstract

Background: Patients with epilepsy (PwE) have an increased risk of active and lifetime depression. Two in 10 patients experience depression. Lack of trained psychiatric staff in low- and middle-income countries (LMIC) creates a need for screening tools that enable detection of depression in PwE. We describe the translation, validity and reliability assessment of the Patient Health Questionnaire-9 (PHQ-9) as a screening tool for depression among PwE in Rwanda.

Method: PHQ-9 was translated to Kinyarwanda using translation-back translation and validated by a discussion group. For validation, PwE of ≥15 years of age were administered the PHQ-9 and Hamilton Depression Rating Scale (HDRS) by trained psychiatry staff at Visit 1. A random sample of 20% repeated PHQ-9 and HDRS after 14 days to assess temporal stability and intra-rater reliability. Internal structure, reliability and external validity were assessed using confirmatory factor analysis, reliability coefficients and HDRS-correlation, respectively. Maximal Youden's index was considered for cut-offs.

Results: Four hundred and thirty-four PwE, mean age 30.5 years (SD ±13.3), were included of whom 33.6%, 37.9%, 13.4%, and 15.1% had no, mild, moderate and severe depression, respectively. PHQ-9 performed well on a one-factor model (unidimensional model), with factor loadings of 0.63-0.86. Reliability coefficients above 0.80 indicated strong internal consistency. Good temporal stability was observed (0.79 [95% CI: 0.68-0.87]). A strong correlation (R = 0.66, p = 0.01) between PHQ-9 and HDRS summed scores demonstrated robust external validity. The optimal cut-off for the PHQ-9 was similar (≥5) for mild and moderate depression and ≥7 for severe depression.

Conclusion: PHQ-9 validation in Kinyarwanda creates the capacity to screen PwE in Rwanda at scores of ≥5 for mild or moderate and ≥7 for severe depression. The availability of validated tools for screening and diagnosis for depression is a forward step for holistic care in a resource-limited environment.

PubMed Disclaimer

Conflict of interest statement

PD has received consultancy fees from UCB Pharma and Novartis. DET is an employee of UCB Pharma. PEB has received speaker and consultancy fees from UCB Pharma and grants from his institution. JNRV received a consultancy fee for the statistical analysis. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Other authors have nothing to disclose.

Figures

Fig 1
Fig 1
Likert responses distribution (A) and correlation pattern between items (B) of the Rwandan version of the PHQ-9. The size of the nodes (circles) represents the average response in the Likert scale for each item. The thickness of the lines (edges) represents the partial correlation between items. Nta na rimwe = not at all, never; Rimwe na rimwe = several days, sometimes; Birenze igice cy’umunsi = more than half the days; Hafi ya buri munsi = nearly every day.
Fig 2
Fig 2. Confirmatory factor analysis models for PHQ-9.

References

    1. Kanner AM, Barry JJ, Gilliam F, Hermann B, Meador KJ. Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events? Epilepsia. 2012;53(6):1104–8. 10.1111/j.1528-1167.2012.03488.x - DOI - PubMed
    1. Fiest KM, Dykeman J, S.B. P, Wiebe S, Kaplan GG, Maxwell CJ, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology. 2013;80(6):590–9. 10.1212/WNL.0b013e31827b1ae0 - DOI - PMC - PubMed
    1. Kwon OY, Park SP. Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: a survey at two tertiary care hospitals. Epilepsy Behav. 2013;26(1):51–6. 10.1016/j.yebeh.2012.10.020 - DOI - PubMed
    1. Leaffer EB, Hesdorffer DC, Begley C. Psychosocial and sociodemographic associates of felt stigma in epilepsy. Epilepsy Behav. 2014;37:104–9. 10.1016/j.yebeh.2014.06.006 - DOI - PubMed
    1. Kwon OY, Park SP. Depression and anxiety in people with epilepsy. J Clin Neurol. 2014;10(3):175–88. 10.3988/jcn.2014.10.3.175 - DOI - PMC - PubMed

Publication types